These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules. Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147 [TBL] [Abstract][Full Text] [Related]
44. Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Rosengard BR; Ojikutu CA; Guzzetta PC; Smith CV; Sundt TM; Nakajima K; Boorstein SM; Hill GS; Fishbein JM; Sachs DH Transplantation; 1992 Sep; 54(3):490-7. PubMed ID: 1412729 [TBL] [Abstract][Full Text] [Related]
45. Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. Knechtle SJ; Wang J; Jiao S; Geissler EK; Sumimoto R; Wolff J Transplantation; 1994 Apr; 57(7):990-6. PubMed ID: 8165719 [TBL] [Abstract][Full Text] [Related]
46. Modulation of alloimmune response by commensal gut microbiota and potential new avenues to influence the outcome of allogeneic transplantation by modification of the 'gut culture'. Kanangat S Int J Immunogenet; 2017 Feb; 44(1):1-6. PubMed ID: 28044415 [TBL] [Abstract][Full Text] [Related]
51. Synergy of class I and class II MHC deficiency (C1D and C2D) islets and early short-term suppression in achieving long-term islet graft survival and tolerance induction. Pittman K; Berzina P; Contreras J; Bilbao G; Thomas F; Thomas J Transplant Proc; 1999; 31(1-2):635-6. PubMed ID: 10083271 [No Abstract] [Full Text] [Related]
52. Chen JC; Ou LS; Chan CC; Kuo ML; Tseng LY; Chang HL Front Immunol; 2018; 9():418. PubMed ID: 29552016 [TBL] [Abstract][Full Text] [Related]
54. Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells. Yu YY; Forman J; Aldrich C; Blazar B; Flaherty L; Kumar V; Bennett M Int Immunol; 1994 Sep; 6(9):1297-306. PubMed ID: 7529556 [TBL] [Abstract][Full Text] [Related]
55. Neonatal tolerance of H-2 alloantigens. I. I region modulation of tolerance potential of K and D antigens. Streilein JW; Klein J Proc R Soc Lond B Biol Sci; 1980 Apr; 207(1169):461-74. PubMed ID: 6104812 [TBL] [Abstract][Full Text] [Related]
56. Ocular production of interferon-gamma and lack of major histocompatibility complex molecules induce immunological changes in the intraocular environment. Geiger KD; Sarvetnick NE Ger J Ophthalmol; 1996 Nov; 5(6):309-14. PubMed ID: 9479510 [TBL] [Abstract][Full Text] [Related]
57. Is there MHC Class II restriction of the response to MHC Class I in transplant patients? Papassavas AC; Barnardo MC; Bunce M; Welsh KI Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447 [TBL] [Abstract][Full Text] [Related]
58. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Wong W; Morris PJ; Wood KJ Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815 [TBL] [Abstract][Full Text] [Related]
59. Host T-cell primary allosensitization to MHC class-I- and class-II-expressing human cardiac myocytes requires the presence of a second signal. Ansari AA; Wang YC; Kanter K; Villinger F; Mayne A; Sell KW; Herskowitz A Hum Immunol; 1993 Jun; 37(2):108-18. PubMed ID: 8226137 [TBL] [Abstract][Full Text] [Related]